Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (e)-4-carboxystyryl-4-chlorobenzylsulfone, Sodium Salt
2. 4-carboxystyryl-4-chlorobenzylsulfone
3. Ex-rad
4. On 01210.na
1. 334969-03-8
2. On 01210
3. (e)-4-(2-((4-chlorobenzyl)sulfonyl)vinyl)benzoic Acid
4. Recilisib [usan]
5. Ex-rad
6. 4-[(e)-2-[(4-chlorophenyl)methylsulfonyl]ethenyl]benzoic Acid
7. F5v4k11syv
8. 4-[(1e)-2-[[(4-chlorophenyl)methyl]sulfonyl]ethenyl]-benzoic Acid
9. On-01210
10. Recilisib (usan)
11. 4-((1e)-2-(((4-chlorophenyl)methyl)sulfonyl)ethenyl)benzoic Acid
12. Benzoic Acid, 4-((1e)-2-(((4-chlorophenyl)methyl)sulfonyl)ethenyl)-
13. On 01210.na
14. Recilisib [usan:inn]
15. Unii-f5v4k11syv
16. Exrad
17. Recilisib [inn]
18. Recilisib [who-dd]
19. On 01210ex-rad
20. Schembl1079736
21. Chembl2219421
22. Gtpl11620
23. Ex-a2906
24. Recilisib; Ex-rad; On 01210
25. Zinc34007613
26. Cs-6712
27. Hy-101625
28. D10346
29. A857575
30. Q27277679
31. (e)-4-(2-((4-chlorobenzyl)sulfonyl)vinyl)benzoicacid
| Molecular Weight | 336.8 g/mol |
|---|---|
| Molecular Formula | C16H13ClO4S |
| XLogP3 | 3.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 5 |
| Exact Mass | 336.0223078 g/mol |
| Monoisotopic Mass | 336.0223078 g/mol |
| Topological Polar Surface Area | 79.8 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 493 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
79
PharmaCompass offers a list of Recilisib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Recilisib manufacturer or Recilisib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Recilisib manufacturer or Recilisib supplier.
PharmaCompass also assists you with knowing the Recilisib API Price utilized in the formulation of products. Recilisib API Price is not always fixed or binding as the Recilisib Price is obtained through a variety of data sources. The Recilisib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Recilisib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Recilisib, including repackagers and relabelers. The FDA regulates Recilisib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Recilisib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Recilisib supplier is an individual or a company that provides Recilisib active pharmaceutical ingredient (API) or Recilisib finished formulations upon request. The Recilisib suppliers may include Recilisib API manufacturers, exporters, distributors and traders.
Recilisib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Recilisib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Recilisib GMP manufacturer or Recilisib GMP API supplier for your needs.
A Recilisib CoA (Certificate of Analysis) is a formal document that attests to Recilisib's compliance with Recilisib specifications and serves as a tool for batch-level quality control.
Recilisib CoA mostly includes findings from lab analyses of a specific batch. For each Recilisib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Recilisib may be tested according to a variety of international standards, such as European Pharmacopoeia (Recilisib EP), Recilisib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Recilisib USP).
